欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0591/005
药品名称Rivaroxaban PharOS Treatment Initiation Pack
活性成分
    • RIVAROXABAN 20.0 mg
    • RIVAROXABAN 15.0 mg
剂型Film-coated tablet
上市许可持有人PharOS Pharmaceutical Oriented Services Limited Lesvou Street (end), Thesi Loggos Industrial Zone Metamorfossi Attica 144 52 Greece Telephone +30 2106664667 Telefax +30 2106664669 E-mail info@pharosgr.gr
参考成员国 - 产品名称Malta (MT)
Rivaroxaban PharOS Treatment Initiation Pack 15mg & 20mg
互认成员国 - 产品名称
    • Iceland (IS)
    • Slovakia (SK)
许可日期2020/01/14
最近更新日期2024/05/22
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase